Pfizer-IIT Delhi Innovation and IP Program_Apply Before 15th November 2016


Registrations open till 15th November 2016

The Pfizer-IIT Delhi Innovation and IP Program is a collaborative incubation accelerator - co-created by Pfizer and Foundation for Innovation and Technology Transfer (FITT) at the Indian Institute of Technology Delhi (IIT Delhi).

The Program will provide - funding, resources, expertise and infrastructure – to propel India’s healthcare innovations from idea to IP.

Pfizer funding through this program will provide an unencumbered grant of upto Rs. 50 lakhs to each innovator – selected through an appropriately drawn up process.

Patents obtained as a result of the incubation shall belong to the innovators, who will be free to commercialize them as they desire.

Two components of the Pfizer IIT Delhi Innovation & IP Program (PIDIIP)
  1. For innovators seeking comprehensive support to translate their healthcare ideas into new business opportunities, the Program provides:
    • Resident incubation at IIT Delhi’s bio-incubator for a period of up to 2 years.
    • Funding of upto INR 50 lakhs for each innovator to take ideas through proof of concept to IP.
    • Mentoring support from IIT Delhi’s faculty and FITT nominated experts.
    • Access to infrastructure, prototyping laboratories and space for setting up an office.
    • IP search and filing services.
    • Guidance from Pfizer’s global experts.
    • Access to venture capitalists and other industry linkages

  1. For innovators who already have a proof of principle /concept and are only looking for IP related support, the program provides:
    • Access to IP counselling services at FITT.
    • Funding support to cover patenting expenses.


Comments

Popular posts from this blog

China-India joint summit discusses bilateral trade to improve pharma industry

Webinar on ‘OPPORTUNITY TO COMMERCIALIZE HERBAL RESEARCH’

WhatsApp Group for Pharma Literati